We investigate whether increased racial diversity of clinical trial principal investigators could increase the enrollment of Black patients, which currently lags population and…
Eligibility criteria for interventions can induce an Ashenfelter Dip, and subsequent mean-reversion may result in improvement over time even absent the intervention. We…
Disparities between Black and White Americans in health care coverage and health outcomes are pervasive in the United States. In this paper, we describe the evolution of the…
The next U.S. president will inherit multiple epidemics with inequitably distributed effects. Kamala Harris and Donald Trump are likely to take divergent policy approaches to…
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher…
In the summer of 2020, George Floyd’s video-graphed murder by Minneapolis police officers sparked a renewed public discourse about the role that police and policing play in the…
The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in…
The COVID-19 pandemic has exacted a historic toll on Americans’ health and longevity. It has also shaped socioeconomic inequalities along the lines of gender, race, ethnicity,…
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population uninsured. We argue that incremental…
Systemic racism is deeply embedded in U.S. healthcare and economic systems and remains pervasive in social policies and organizational practices that perpetuate oppression of…
